FIELD: medicine.
SUBSTANCE: what is involved is the immunopathological examination using indirect immunofluorescence. At the first stage, patient's serum is incubated on monkey's renal tissue section; at the second stage; it is incubated with goat anti-species fluorescent serum. The reaction is recorded by fluorescence microscopy by specifying the number of renal tubules with a fluorescent basal membrane and expressing the measurement as a percentage. If the derived value exceeds 15%, a considerable increase of the probability of the non-surgical treatment failure is predicted.
EFFECT: method is easy to implement; it takes 2 hours to be implemented and requires no expensive chemicals to be used.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF THERAPY OF ULCERATIVE COLITIS | 2024 |
|
RU2824983C1 |
| METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN ULCERATIVE COLITIS | 2012 |
|
RU2504779C1 |
| METHOD FOR PROGNOSTICATING EFFICIENCY OF THERAPY IN PATIENTS WITH NONSPECIFIC ULCERATIVE COLITIS | 1991 |
|
RU2006033C1 |
| METHOD FOR INDIVIDUAL SENSITIVITY TO PREPARATIONS OF 5-AMINOSALYCILIC ACID (5-ASA) IN PATIENTS WITH ULCEROUS COLITIS | 2005 |
|
RU2287819C1 |
| METHOD OF TREATMENT OF NONSPECIFIC ULCER COLITIS | 1994 |
|
RU2089218C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF ULCERATIVE COLITIS AND CROHN'S DISEASE IN ACUTE STAGE | 2023 |
|
RU2825531C1 |
| METHOD FOR TREATING ULCERATIVE COLITIS | 2000 |
|
RU2165758C1 |
| METHOD OF TREATING ULCERATIVE COLITIS | 2023 |
|
RU2807131C1 |
| AGENT FOR CELL METABOLIC PROCESS REGULATION | 2011 |
|
RU2487720C1 |
| METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF ULCERATIVE COLITIS AND CROHN'S DISEASE IN THE ACUTE STAGE | 2021 |
|
RU2786142C1 |
